Navigation Links
Natural Capital Project to develop conservation software
Date:12/1/2008

The Natural Capital Projecta collaboration of Stanford University's Woods Institute for the Environment, The Nature Conservancy and the World Wildlife Fundhas been awarded a two-year, $1.97 million grant from the Gordon and Betty Moore Foundation to develop a software program for mapping and evaluating the economic benefits provided by temperate marine ecosystems.

Called Marine InVEST (Integrated Valuation of Ecosystem Services and Tradeoffs), the proposed software will give policymakers and other stakeholders an easy-to-use program for calculating the multitude of services that people derive from ocean ecosystems and incorporating those values into the planning process.

"With Marine InVEST, people will be able to look at a comprehensive ocean management plan and ask what the monetary consequences of different plan configurations will be for a number of different ecosystem services, like fishing, shoreline protection, shipping, tourism and recreation," said Heather Tallis, lead scientist at the Natural Capital Project. "There are always tradeoffs in any planning process, but it's hard to get a sense of how big those tradeoffs are likely to be when you have to guess. Marine InVEST will let you get real numbers and use that information to pick the outcome that has the best balance."

Tallis said that when the software is ready in 2009, it will be tested at a coastal site in California or British Columbia. "There is a lot of interest right now in establishing ocean zoning as a major approach to ocean management that maximizes in a sustainable fashion the totalenvironmental, social and economicvalue from the marine environment," she said. "That's a hard thing to do given the current science. So it's a really great time for us to be able to develop a tool like this."

The Marine InVEST research grant is led by Natural Capital Project Chair Gretchen Daily, the Bing Professor in Environmental Science and a senior fellow at the Woods I
'/>"/>

Contact: Mark Shwartz
mshwartz@stanford.edu
650-723-9296
Stanford University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Natural chemical found in broccoli helps combat skin blistering disease
2. Natural insecticide re-created in the lab
3. Researchers develop simple method to create natural drug products
4. Brains timing linked with timescales of the natural visual world
5. Alternative methods proposed to detect pesticides and antibiotics in water and natural food
6. Naturally-occurring apple compounds reduce risk of pancreatic cancer
7. New membrane strips carbon dioxide from natural gas faster and better
8. Natural product discovery by Cleveland medical researchers blocks tissue destruction
9. MU researchers go nano, natural and green
10. Researchers discover natural herbicide released by grass
11. Baker Institute finds increased domestic production wont make US self-sufficient in natural gas

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... children with cancer, the hopeful news is that pe...decades. Among the bad newstreatments that enable ...osed with cancer who have reached puberty currentl... before undergoing cancer treatment, they may have...Younger boys, however, do not produce sperm, altho...
(Date:11/9/2009)...Ala. The U.S. Department of Energy (DOE) has anno...Alabama at Birmingham (UAB) School of Engineering ...gas emissions through the capture and permanent sa...O2). The project is in collaboration with Southern... Funded by the DOE through the 2009 American Recov...
(Date:11/9/2009)...ournal Naturwissenschaften is publishing a speci...dern Biology" to commemorate Darwin,s On the Origi...November 1859. Guest editor and author of the lead...nt physiology and evolutionary biology at the Univ...special issue are available free of charge until 3...
Breaking Biology News(10 mins):For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3Allied Worlds Susan Chmieleski to Speak at American Society for Healthcare Risk Management 28ASHRM 29 Annual Conference and Exhibition 59740 1Allied Worlds Susan Chmieleski to Speak at American Society for Healthcare Risk Management 28ASHRM 29 Annual Conference and Exhibition 59740 2Allied Worlds Susan Chmieleski to Speak at American Society for Healthcare Risk Management 28ASHRM 29 Annual Conference and Exhibition 59740 3New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 1New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 2New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 3New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 4New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 5New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 6New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 7New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 8New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 9New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 10New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 11New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 12New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 13New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 14New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 15New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 16New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 17New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 18New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 19New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 20New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 21New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 22Ikaria 28R 29 Names New Chairman 14523 1Ikaria 28R 29 Names New Chairman 14523 2
...ts including researchers at Cold Spring Harbor Lab...irst biomarker that permits neural stem and progen...n the brains of living human subjects. This import...gnosis and monitoring of brain tumors and a range ... , The biomarker is a lipid molecule whose presen...
...e National Institute of Standards of Technology (N... what is probably the worlds smallest microwave ov... drop of liquid inside a container slightly shorte...he micro microwave is intended for lab-on-a-chip d...es on tiny samples. , In a paper in the November ...
...ajor component of green tea could prove the perfec...tem response to a bacterial infection. In a new la...n Institute for Medical Research, and his colleagu...zens of Chinese herbal compounds in reversing a fa...very year. They found that an ingredient in green ...
Other Biology News:Team of scientists develops non-invasive method to track nerve-cell development in live human brain 2Micro microwave does pinpoint cooking for miniaturized labs 2In the laboratory, green tea proves a powerful medicine against severe sepsis 2
(Date:11/8/2009)...lif. Nov. 5, 2009 Complete Genomics, a third-gen...ounced publication of a report in the journal Sci...atform, including analysis of sequence data from t...for these three genomes sequenced on the proof-of-...5 for 87x coverage to $1,726 for 45x coverage for ...
(Date:11/6/2009)... 6 BioSpecifics Technolo...ompany developing first-in-class collagenase-based...or the third quarter ended September 30, 2009. ,... this year, the FDA,s Arthritis Advisory Committee...pproval of XIAFLEX(TM) for the treatment of Dupuyt...
(Date:11/6/2009)... November 6 EUCODIS Bioscience, a ...d marketing enzymes for the,chemical industry anno...reement with Bio Sidus, the leading biopharmaceuti...ment gives EUCODIS Bioscience exclusive access - f...s, proprietary collection of,psychrophilic bacteri...
(Date:11/6/2009)...ewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:...today announced updated results from a Phase II st...rcomas metastatic to the lung in a poster presenta... Society Meeting held in Miami Beach, Florida, fro...titled "A Phase II Study of Intravenous REOLYSIN (...
Breaking Biology Technology:Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3
...rmaceuticals,Inc. (Nasdaq: CADX ), a biopharmaceu...nd commercializing proprietary product candidates ...nced today that the company,s,President and CEO Th...ew on,Monday, June 23, 2008 at 1:05pm Eastern Time...ain Roundtable Conference at the Sofitel Hotel in ...
...nies, The Integra Group of Brooklyn Park and, Na...speed the path to market for advances ...and SAN DIEGO, June 17 Coinciding,with the BIO In...terventions introduces the "Mouse Stent Model" for...s. The model, complete with a mini-stent of,specta...
...,s focus in key areas in contract research, includ...l monitoring, and data management/e...7 PROMETRIKA, LLC, a contract,research organizati...vices,for clients in pharmaceuticals, biologics an...es Kolb has joined the company as senior director,...
Other Biology Technology:Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York 2NanoInterventions Launches New, Rapid Testing System for Coronary Stents 2NanoInterventions Launches New, Rapid Testing System for Coronary Stents 3Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and Data Management 2Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and Data Management 3
CoverWell imaging chamber gasket with adhesive, one chamber, 20 mm diameter, 1.0 mm deep *set of 40* from Molecular Probes (Invitrogen)
Canine IL-10 ELISpot Development Kit from R&D Systems
Equine TNF ALPHA from AbD Serotec
DETACHaBEAD CD19 from Dynal Biotech
Biology Products: